Clinical Trials Browser

NETWORK × atezolizumab × Dermatologic × Clear all

NCT03357224 2024-02-22

PARCT

Phase 2 Terminated

DermatologicLymphoid

Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous